ESP Pharma
Date | Investors | Amount | Round |
---|---|---|---|
N/A | $24.0m | Series A | |
$20.0m | Series B | ||
$475m Valuation: $475m | Acquisition | ||
Total Funding | €40.0m |
Recent News about ESP Pharma
EditESP Pharma is a Hong Kong-based company specializing in sourcing and delivering affordable brand name and generic medications from licensed and reputable pharmacies worldwide. The company serves cost-conscious consumers looking for quality pharmaceutical products at the lowest possible prices. Operating in the global pharmaceutical market, ESP Pharma collaborates with affiliate pharmacies to find the best deals on popular medications and passes these savings directly to customers. The business model revolves around sourcing medications from established pharmacies, ensuring quality and compliance, and then exporting these products by post to various countries. Revenue is generated through the sale of these medications, often at prices significantly lower than local pharmacies. The company guarantees delivery and customer satisfaction, providing free prescription consultations with all orders.
Keywords: affordable medications, global pharmacies, brand name drugs, generic drugs, cost-conscious consumers, prescription consults, quality assurance, licensed pharmacies, global delivery, customer satisfaction.